Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications.

Huang W, Wen Z, Tourmouzis K, Huang L, Goldstein SM, Natke E, Honkanen R, Rigas B

DOI: 10.3389/fddev.2026.1778440
Published: 2026
Container: Frontiers in drug delivery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fddev.2026.1778440,
  title = {Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications.},
  author = {Huang W and Wen Z and Tourmouzis K and Huang L and Goldstein SM and Natke E and Honkanen R and Rigas B},
  year = {2026},
  journal = {Frontiers in drug delivery},
  doi = {10.3389/fddev.2026.1778440},
  url = {https://doi.org/10.3389/fddev.2026.1778440}
}

RIS

TY  - JOUR
TI  - Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications.
AU  - Huang W
AU  - Wen Z
AU  - Tourmouzis K
AU  - Huang L
AU  - Goldstein SM
AU  - Natke E
AU  - Honkanen R
AU  - Rigas B
PY  - 2026
JO  - Frontiers in drug delivery
DO  - 10.3389/fddev.2026.1778440
UR  - https://doi.org/10.3389/fddev.2026.1778440
ER  -

APA

W, H., Z, W., K, T., L, H., SM, G., E, N., R, H., & B, R. (2026). Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications.. Frontiers in drug delivery. https://doi.org/10.3389/fddev.2026.1778440

Source records

pubmed · retrieved 2026-09-26T05:39:33.250Z